Be the first to know what’s next in global innovation.
Join our community of founders, leaders, and partners to get our latest insights and ecosystem updates delivered straight to your inbox.

The United Kingdom is at the forefront of health & longevity innovation, driving advancements that are transforming patient care and medical research.
Researchers are pioneering the use of artificial intelligence (AI) in diagnostics, enabling earlier detection of diseases such as cancer through advanced imaging and data analysis. The country’s biotech sector is advancing gene therapy and regenerative medicine, offering new hope for treating previously incurable conditions.
These efforts are positioning the UK as a global leader in creating more effective, efficient, and personalized healthcare solutions.
Health & Longevity Innovation









Be the first to know what’s next in global innovation.
Join our community of founders, leaders, and partners to get our latest insights and ecosystem updates delivered straight to your inbox.

The gut microbiome is one of the most powerful and potentially modifiable levers we have to influence how we age. As the link between the microbiome and longevity becomes clearer and corporate interest in the space continues to grow, our Plug and Play Ventures team in France is exploring the current landscape, from the research shaping the field to the startups, corporations, and investors turning longevity science into real-world products.

Katie Greenshields

Salim Laouiti

Helena Turck
How we help our Health & Longevity partners innovate

We have a community of experts all over the world. We work as a bridge between Silicon Valley and the rest of the world, making innovation open to anyone, anywhere.